Phase 3, Prospective, Randomized, Multi-Center Clinical Study Comparing the Safety and Efficacy of BAX855 Following PK Guided Prophylaxis Targeting Two Different FVIII Through Levels in Subjects with Severe Hemophilia A

Radulescu, Vlad (PI)

Pediatrics

Status	Finished
Effective start/end date	10/6/17 → 12/6/18

Funding

Baxalta Innovations GmbH: $20,287.00

1 Finished

Residual Scope: Phase 3, Prospective, Randomized, Multi-Center Clinical Study Comparing the Safety and Efficacy of BAX855 Following PK Guided Prophylaxis Targeting Two Different FVIII Through Levels in Subjects with Severe Hemophilia A
Radulescu, V. (PI)
Baxalta Innovations GmbH
10/6/17 → 12/6/18
Project: Research project